- Home
- TLSI vs FUND Comparison
TLSI vs FUND Comparison
Compare TLSI & FUND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- FUND
- Stock Information
- Founded
- TLSI 2010
- FUND 1988
- Country
- TLSI United States
- FUND Canada
- Employees
- TLSI N/A
- FUND N/A
- Industry
- TLSI Medical Specialities
- FUND Investment Managers
- Sector
- TLSI Health Care
- FUND Finance
- Exchange
- TLSI Nasdaq
- FUND Nasdaq
- Market Cap
- TLSI 204.0M
- FUND 231.6M
- IPO Year
- TLSI N/A
- FUND N/A
- Fundamental
- Price
- TLSI $4.56
- FUND $7.79
- Analyst Decision
- TLSI Strong Buy
- FUND
- Analyst Count
- TLSI 5
- FUND 0
- Target Price
- TLSI $10.90
- FUND N/A
- AVG Volume (30 Days)
- TLSI 134.8K
- FUND 32.5K
- Earning Date
- TLSI 08-13-2025
- FUND 01-01-0001
- Dividend Yield
- TLSI N/A
- FUND 6.64%
- EPS Growth
- TLSI N/A
- FUND N/A
- EPS
- TLSI N/A
- FUND 0.93
- Revenue
- TLSI $32,141,000.00
- FUND N/A
- Revenue This Year
- TLSI $55.39
- FUND N/A
- Revenue Next Year
- TLSI $54.89
- FUND N/A
- P/E Ratio
- TLSI N/A
- FUND $8.33
- Revenue Growth
- TLSI 46.20
- FUND N/A
- 52 Week Low
- TLSI $3.50
- FUND $6.75
- 52 Week High
- TLSI $6.04
- FUND $8.47
- Technical
- Relative Strength Index (RSI)
- TLSI 39.21
- FUND 59.51
- Support Level
- TLSI $4.41
- FUND $7.63
- Resistance Level
- TLSI $4.73
- FUND $7.88
- Average True Range (ATR)
- TLSI 0.22
- FUND 0.09
- MACD
- TLSI -0.02
- FUND -0.00
- Stochastic Oscillator
- TLSI 18.99
- FUND 63.33
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About FUND Sprott Focus Trust Inc.
Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.